Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015

To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneum...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Medicine (Baltimore) 2019-05, Vol.98 (21), p.e15779-e15779
Hauptverfasser: Pedraza-Serrano, Fernando, Jiménez-García, Rodrigo, López-de-Andrés, Ana, Hernández-Barrera, Valentin, Sánchez-Muñoz, Gema, Puente-Maestu, Luis, de-Miguel-Díez, Javier
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e15779
container_issue 21
container_start_page e15779
container_title Medicine (Baltimore)
container_volume 98
creator Pedraza-Serrano, Fernando
Jiménez-García, Rodrigo
López-de-Andrés, Ana
Hernández-Barrera, Valentin
Sánchez-Muñoz, Gema
Puente-Maestu, Luis
de-Miguel-Díez, Javier
description To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used.
doi_str_mv 10.1097/MD.0000000000015779
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6571208</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2232125707</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</originalsourceid><addsrcrecordid>eNpdkctuFDEQRa0IRIbAF0SKvGRBBz_b7Q0SmvCSErFIWFsVtzvtxNNubDcj-Ho8TBIe3pTkOvdWqS5Cx5ScUqLVm4uzU_LnUamUPkArKnnbSN2KJ2hFCJON0kocouc531aIKyaeoUNOKRNakRUK6xES2OKSz8XbjGHqcVyKjRuXcRzwDMW7qWQ8xjz7AsH_dD3e-jJiP1VZVRUPAYdlusG9zw5yFfoJX87gp9eYESpwibsqX6CnA4TsXt7XI_T1w_ur9afm_MvHz-t3540VkrQNkwMfOBMcWut6JTunKYWO2t5aIvWgO3kNLWNKKOqoJQ6IhE5rSTmnpO_5EXq7952X643rbd0_QTBz8htIP0wEb_7tTH40N_G7aaWijHTV4NW9QYrfFpeL2fhsXQgwubhkwxhnlElFVEX5HrUp5pzc8DiGErPLyVycmf9zqqqTvzd81DwEUwGxB7Yx7K58F5atS2Z0EMr4208qzZp6VU0kE6SpP6LlvwDApZ3Z</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2232125707</pqid></control><display><type>article</type><title>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</title><source>Wolters Kluwer Open Health</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>IngentaConnect Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Pedraza-Serrano, Fernando ; Jiménez-García, Rodrigo ; López-de-Andrés, Ana ; Hernández-Barrera, Valentin ; Sánchez-Muñoz, Gema ; Puente-Maestu, Luis ; de-Miguel-Díez, Javier</creator><creatorcontrib>Pedraza-Serrano, Fernando ; Jiménez-García, Rodrigo ; López-de-Andrés, Ana ; Hernández-Barrera, Valentin ; Sánchez-Muñoz, Gema ; Puente-Maestu, Luis ; de-Miguel-Díez, Javier</creatorcontrib><description>To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used.</description><identifier>ISSN: 0025-7974</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000015779</identifier><identifier>PMID: 31124970</identifier><language>eng</language><publisher>United States: the Author(s). Published by Wolters Kluwer Health, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Alveolitis, Extrinsic Allergic - diagnostic imaging ; Alveolitis, Extrinsic Allergic - epidemiology ; Child ; Comorbidity ; Cryptogenic Organizing Pneumonia - diagnostic imaging ; Cryptogenic Organizing Pneumonia - epidemiology ; Diabetes Mellitus - epidemiology ; Female ; Heart Failure - epidemiology ; Histiocytosis, Langerhans-Cell - diagnostic imaging ; Histiocytosis, Langerhans-Cell - epidemiology ; Hospital Mortality ; Hospitalization - statistics &amp; numerical data ; Humans ; Idiopathic Pulmonary Fibrosis - diagnostic imaging ; Idiopathic Pulmonary Fibrosis - epidemiology ; Lung - diagnostic imaging ; Lung Diseases, Interstitial - diagnostic imaging ; Lung Diseases, Interstitial - epidemiology ; Male ; Middle Aged ; Observational Study ; Pulmonary Disease, Chronic Obstructive - epidemiology ; Retrospective Studies ; Sarcoidosis - diagnostic imaging ; Sarcoidosis - epidemiology ; Spain - epidemiology ; Tomography, X-Ray Computed - statistics &amp; numerical data ; Young Adult</subject><ispartof>Medicine (Baltimore), 2019-05, Vol.98 (21), p.e15779-e15779</ispartof><rights>the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</citedby><cites>FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571208/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571208/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31124970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pedraza-Serrano, Fernando</creatorcontrib><creatorcontrib>Jiménez-García, Rodrigo</creatorcontrib><creatorcontrib>López-de-Andrés, Ana</creatorcontrib><creatorcontrib>Hernández-Barrera, Valentin</creatorcontrib><creatorcontrib>Sánchez-Muñoz, Gema</creatorcontrib><creatorcontrib>Puente-Maestu, Luis</creatorcontrib><creatorcontrib>de-Miguel-Díez, Javier</creatorcontrib><title>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alveolitis, Extrinsic Allergic - diagnostic imaging</subject><subject>Alveolitis, Extrinsic Allergic - epidemiology</subject><subject>Child</subject><subject>Comorbidity</subject><subject>Cryptogenic Organizing Pneumonia - diagnostic imaging</subject><subject>Cryptogenic Organizing Pneumonia - epidemiology</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Female</subject><subject>Heart Failure - epidemiology</subject><subject>Histiocytosis, Langerhans-Cell - diagnostic imaging</subject><subject>Histiocytosis, Langerhans-Cell - epidemiology</subject><subject>Hospital Mortality</subject><subject>Hospitalization - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Idiopathic Pulmonary Fibrosis - diagnostic imaging</subject><subject>Idiopathic Pulmonary Fibrosis - epidemiology</subject><subject>Lung - diagnostic imaging</subject><subject>Lung Diseases, Interstitial - diagnostic imaging</subject><subject>Lung Diseases, Interstitial - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Observational Study</subject><subject>Pulmonary Disease, Chronic Obstructive - epidemiology</subject><subject>Retrospective Studies</subject><subject>Sarcoidosis - diagnostic imaging</subject><subject>Sarcoidosis - epidemiology</subject><subject>Spain - epidemiology</subject><subject>Tomography, X-Ray Computed - statistics &amp; numerical data</subject><subject>Young Adult</subject><issn>0025-7974</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctuFDEQRa0IRIbAF0SKvGRBBz_b7Q0SmvCSErFIWFsVtzvtxNNubDcj-Ho8TBIe3pTkOvdWqS5Cx5ScUqLVm4uzU_LnUamUPkArKnnbSN2KJ2hFCJON0kocouc531aIKyaeoUNOKRNakRUK6xES2OKSz8XbjGHqcVyKjRuXcRzwDMW7qWQ8xjz7AsH_dD3e-jJiP1VZVRUPAYdlusG9zw5yFfoJX87gp9eYESpwibsqX6CnA4TsXt7XI_T1w_ur9afm_MvHz-t3540VkrQNkwMfOBMcWut6JTunKYWO2t5aIvWgO3kNLWNKKOqoJQ6IhE5rSTmnpO_5EXq7952X643rbd0_QTBz8htIP0wEb_7tTH40N_G7aaWijHTV4NW9QYrfFpeL2fhsXQgwubhkwxhnlElFVEX5HrUp5pzc8DiGErPLyVycmf9zqqqTvzd81DwEUwGxB7Yx7K58F5atS2Z0EMr4208qzZp6VU0kE6SpP6LlvwDApZ3Z</recordid><startdate>20190501</startdate><enddate>20190501</enddate><creator>Pedraza-Serrano, Fernando</creator><creator>Jiménez-García, Rodrigo</creator><creator>López-de-Andrés, Ana</creator><creator>Hernández-Barrera, Valentin</creator><creator>Sánchez-Muñoz, Gema</creator><creator>Puente-Maestu, Luis</creator><creator>de-Miguel-Díez, Javier</creator><general>the Author(s). Published by Wolters Kluwer Health, Inc</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190501</creationdate><title>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</title><author>Pedraza-Serrano, Fernando ; Jiménez-García, Rodrigo ; López-de-Andrés, Ana ; Hernández-Barrera, Valentin ; Sánchez-Muñoz, Gema ; Puente-Maestu, Luis ; de-Miguel-Díez, Javier</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4506-25f3f3243a6ced758e911a81cdcc059f985ba6227471e1c0ea05a899513310dd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alveolitis, Extrinsic Allergic - diagnostic imaging</topic><topic>Alveolitis, Extrinsic Allergic - epidemiology</topic><topic>Child</topic><topic>Comorbidity</topic><topic>Cryptogenic Organizing Pneumonia - diagnostic imaging</topic><topic>Cryptogenic Organizing Pneumonia - epidemiology</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Female</topic><topic>Heart Failure - epidemiology</topic><topic>Histiocytosis, Langerhans-Cell - diagnostic imaging</topic><topic>Histiocytosis, Langerhans-Cell - epidemiology</topic><topic>Hospital Mortality</topic><topic>Hospitalization - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Idiopathic Pulmonary Fibrosis - diagnostic imaging</topic><topic>Idiopathic Pulmonary Fibrosis - epidemiology</topic><topic>Lung - diagnostic imaging</topic><topic>Lung Diseases, Interstitial - diagnostic imaging</topic><topic>Lung Diseases, Interstitial - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Observational Study</topic><topic>Pulmonary Disease, Chronic Obstructive - epidemiology</topic><topic>Retrospective Studies</topic><topic>Sarcoidosis - diagnostic imaging</topic><topic>Sarcoidosis - epidemiology</topic><topic>Spain - epidemiology</topic><topic>Tomography, X-Ray Computed - statistics &amp; numerical data</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pedraza-Serrano, Fernando</creatorcontrib><creatorcontrib>Jiménez-García, Rodrigo</creatorcontrib><creatorcontrib>López-de-Andrés, Ana</creatorcontrib><creatorcontrib>Hernández-Barrera, Valentin</creatorcontrib><creatorcontrib>Sánchez-Muñoz, Gema</creatorcontrib><creatorcontrib>Puente-Maestu, Luis</creatorcontrib><creatorcontrib>de-Miguel-Díez, Javier</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pedraza-Serrano, Fernando</au><au>Jiménez-García, Rodrigo</au><au>López-de-Andrés, Ana</au><au>Hernández-Barrera, Valentin</au><au>Sánchez-Muñoz, Gema</au><au>Puente-Maestu, Luis</au><au>de-Miguel-Díez, Javier</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2019-05-01</date><risdate>2019</risdate><volume>98</volume><issue>21</issue><spage>e15779</spage><epage>e15779</epage><pages>e15779-e15779</pages><issn>0025-7974</issn><eissn>1536-5964</eissn><abstract>To assess characteristics and outcomes of patients hospitalized with interstitial lung diseases (ILD) and to analyze patient's comorbidities, procedures, and in-hospital outcomes.We identified patients hospitalized with idiopathic pulmonary fibrosis and others ILD such as hypersensitivity pneumonitis, cryptogenic organizing pneumonia, lymphangioleiomyomatosis, pulmonary Langerhans cell histiocytosis, and sarcoidosis in Spain during 2014 and 2015.We identified 14,565 discharges among patients admitted for ILD in Spain during the study period: idiopathic pulmonary fibrosis (IPF) in 42.32% (n = 6164), sarcoidosis in 37.65% (n = 5484), hypersensitivity pneumonitis in 10.55% (n = 1538), cryptogenic organizing pneumonia in 7.06% (n = 1028), pulmonary Langerhans cell histiocytosis in 1.48% (n = 215), and lymphangioleiomyomatosis in 0.94% (n = 136). The most common associated comorbidities according to those included in the Charlson Comorbidity Index (CCI) were COPD, diabetes, and congestive heart disease. The presence of pulmonary hypertension increased the probability of dying in patients with idiopathic pulmonary fibrosis (OR 1.36; 95%CI 1.06-1.73). Patients with cryptogenic organizing pneumonia had the longest length of hospital stay and the highest percentage of hospital readmissions (23.64%). The highest IHM corresponded to the idiopathic pulmonary fibrosis (14.94%). Computed tomography of the chest was the procedure more used during admissions for ILD.IPF was responsible for larger percentage of hospital admission among ILD in our study. In addition, the IHM were higher in IPF patients in comparison with those with other ILD. The most common associated comorbidity in ILD according to those included in the CCI was COPD. Computed tomography of the chest was the procedure more frequently used.</abstract><cop>United States</cop><pub>the Author(s). Published by Wolters Kluwer Health, Inc</pub><pmid>31124970</pmid><doi>10.1097/MD.0000000000015779</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2019-05, Vol.98 (21), p.e15779-e15779
issn 0025-7974
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6571208
source Wolters Kluwer Open Health; MEDLINE; DOAJ Directory of Open Access Journals; IngentaConnect Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection
subjects Adolescent
Adult
Aged
Aged, 80 and over
Alveolitis, Extrinsic Allergic - diagnostic imaging
Alveolitis, Extrinsic Allergic - epidemiology
Child
Comorbidity
Cryptogenic Organizing Pneumonia - diagnostic imaging
Cryptogenic Organizing Pneumonia - epidemiology
Diabetes Mellitus - epidemiology
Female
Heart Failure - epidemiology
Histiocytosis, Langerhans-Cell - diagnostic imaging
Histiocytosis, Langerhans-Cell - epidemiology
Hospital Mortality
Hospitalization - statistics & numerical data
Humans
Idiopathic Pulmonary Fibrosis - diagnostic imaging
Idiopathic Pulmonary Fibrosis - epidemiology
Lung - diagnostic imaging
Lung Diseases, Interstitial - diagnostic imaging
Lung Diseases, Interstitial - epidemiology
Male
Middle Aged
Observational Study
Pulmonary Disease, Chronic Obstructive - epidemiology
Retrospective Studies
Sarcoidosis - diagnostic imaging
Sarcoidosis - epidemiology
Spain - epidemiology
Tomography, X-Ray Computed - statistics & numerical data
Young Adult
title Characteristics and outcomes of patients hospitalized with interstitial lung diseases in Spain, 2014 to 2015
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T14%3A21%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20outcomes%20of%20patients%20hospitalized%20with%20interstitial%20lung%20diseases%20in%20Spain,%202014%20to%202015&rft.jtitle=Medicine%20(Baltimore)&rft.au=Pedraza-Serrano,%20Fernando&rft.date=2019-05-01&rft.volume=98&rft.issue=21&rft.spage=e15779&rft.epage=e15779&rft.pages=e15779-e15779&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000015779&rft_dat=%3Cproquest_pubme%3E2232125707%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2232125707&rft_id=info:pmid/31124970&rfr_iscdi=true